Low dose combined oral contraceptives induced thrombotic anterior wall myocardial infarction: a case report
Open Access
- 19 April 2020
- journal article
- case report
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 20 (1) , 1-5
Abstract
Background: Combined oral contraceptive pills are associated with an established risk for venous thrombosis; however, their risk for arterial thrombosis remains uncertain, especially with the development of low dose new generations of combined oral contraceptive. Arterial thrombosis is less likely to occur with the use of oral contraceptive pills in the absence of cardiovascular risk factors. Case presentation: We report a 35-year old female with no cardiovascular risk factors who presented with thrombotic anterior wall myocardial infarction 6 months after using a third generation low dose combined oral contraceptive pills (Marvelon; ethinylestradiol 30 mcg and desogestrel 150 mcg). Conclusion: Third generation low dose combined oral contraceptives may lead to myocardial infarction in young women, even in the absence of other cardiovascular risk factors.Keywords
This publication has 11 references indexed in Scilit:
- Low-dose oral contraceptive-induced acute myocardial infarctionThe European Journal of Contraception & Reproductive Health Care, 2016
- Combined oral contraceptives: the risk of myocardial infarction and ischemic strokeCochrane Database of Systematic Reviews, 2015
- Mechanisms of Estrogen-Induced Venous ThromboembolismThrombosis Research, 2010
- Hormone Replacement Therapy and the Cardiovascular SystemJACC, 2006
- Venous and Arterial Thrombosis during Oral Contraceptive Use: Risks and Risk FactorsSeminars in Vascular Medicine, 2003
- The RATIO study: oral contraceptives and the risk of peripheral arterial disease in young womenJournal of Thrombosis and Haemostasis, 2003
- Effects of progestogens on thrombosis and atherosclerosisHuman Reproduction Update, 1999
- Norgestimate: A clinical overview of a new progestinAmerican Journal of Obstetrics and Gynecology, 1992
- The Effects of Different Formulations of Oral Contraceptive Agents on Lipid and Carbohydrate MetabolismNew England Journal of Medicine, 1990
- Oral contraceptives and myocardial infarctionAmerican Journal of Obstetrics and Gynecology, 1990